• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病中的内皮功能障碍因糖化脂蛋白而加重;新型分子疗法。

Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies.

作者信息

Toma Laura, Stancu Camelia Sorina, Sima Anca Volumnia

机构信息

Lipidomics Department, Institute of Cellular Biology and Pathology "Nicolae Simionescu" of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania.

出版信息

Biomedicines. 2020 Dec 27;9(1):18. doi: 10.3390/biomedicines9010018.

DOI:10.3390/biomedicines9010018
PMID:33375461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7823542/
Abstract

Diabetes and its vascular complications affect an increasing number of people. This disease of epidemic proportion nowadays involves abnormalities of large and small blood vessels, all commencing with alterations of the endothelial cell (EC) functions. Cardiovascular diseases are a major cause of death and disability among diabetic patients. In diabetes, EC dysfunction (ECD) is induced by the pathological increase of glucose and by the appearance of advanced glycation end products (AGE) attached to the plasma proteins, including lipoproteins. AGE proteins interact with their specific receptors on EC plasma membrane promoting activation of signaling pathways, resulting in decreased nitric oxide bioavailability, increased intracellular oxidative and inflammatory stress, causing dysfunction and finally apoptosis of EC. Irreversibly glycated lipoproteins (AGE-Lp) were proven to have an important role in accelerating atherosclerosis in diabetes. The aim of the present review is to present up-to-date information connecting hyperglycemia, ECD and two classes of glycated Lp, glycated low-density lipoproteins and glycated high-density lipoproteins, which contribute to the aggravation of diabetes complications. We will highlight the role of dyslipidemia, oxidative and inflammatory stress and epigenetic risk factors, along with the specific mechanisms connecting them, as well as the new promising therapies to alleviate ECD in diabetes.

摘要

糖尿病及其血管并发症影响着越来越多的人。如今这种具有流行趋势的疾病涉及大血管和小血管的异常,所有这些都始于内皮细胞(EC)功能的改变。心血管疾病是糖尿病患者死亡和致残的主要原因。在糖尿病中,葡萄糖病理性增加以及与包括脂蛋白在内的血浆蛋白结合的晚期糖基化终产物(AGE)的出现会诱发内皮细胞功能障碍(ECD)。AGE蛋白与其在EC质膜上的特异性受体相互作用,促进信号通路的激活,导致一氧化氮生物利用度降低、细胞内氧化和炎症应激增加,从而引起EC功能障碍并最终导致其凋亡。不可逆糖化脂蛋白(AGE-Lp)被证明在加速糖尿病患者动脉粥样硬化方面起重要作用。本综述的目的是介绍有关高血糖、ECD以及两类糖化脂蛋白(糖化低密度脂蛋白和糖化高密度脂蛋白)的最新信息,这些因素会导致糖尿病并发症的加重。我们将强调血脂异常、氧化和炎症应激以及表观遗传风险因素的作用,以及将它们联系起来的具体机制,还有减轻糖尿病患者ECD的新的有前景的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/7823542/f5879d7d87fa/biomedicines-09-00018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/7823542/292f4540b070/biomedicines-09-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/7823542/0a1e361098b4/biomedicines-09-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/7823542/f5879d7d87fa/biomedicines-09-00018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/7823542/292f4540b070/biomedicines-09-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/7823542/0a1e361098b4/biomedicines-09-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8979/7823542/f5879d7d87fa/biomedicines-09-00018-g003.jpg

相似文献

1
Endothelial Dysfunction in Diabetes Is Aggravated by Glycated Lipoproteins; Novel Molecular Therapies.糖尿病中的内皮功能障碍因糖化脂蛋白而加重;新型分子疗法。
Biomedicines. 2020 Dec 27;9(1):18. doi: 10.3390/biomedicines9010018.
2
Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.糖基化会放大脂蛋白(a)诱导的人血管内皮细胞纤溶调节因子生成的改变。
Atherosclerosis. 2000 Jun;150(2):299-308. doi: 10.1016/s0021-9150(99)00381-0.
3
Hyperglycemia, lipoprotein glycation, and vascular disease.高血糖、脂蛋白糖化与血管疾病。
Angiology. 2005 Jul-Aug;56(4):431-8. doi: 10.1177/000331970505600411.
4
Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis.脂蛋白在动脉粥样硬化内皮细胞功能障碍中的双重作用。
Cell Tissue Res. 2012 Aug;349(2):433-46. doi: 10.1007/s00441-012-1437-1. Epub 2012 May 18.
5
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.2型糖尿病血管功能障碍的机制、意义及治疗:聚焦于调脂治疗
Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003.
6
Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.氧化型和糖化型脂蛋白对血管内皮细胞纤溶调节因子生成的影响及机制
Mol Cell Biochem. 2003 Apr;246(1-2):69-74.
7
Proteomic study of endothelial dysfunction induced by AGEs and its possible role in diabetic cardiovascular complications.AGEs 诱导的内皮功能障碍的蛋白质组学研究及其在糖尿病心血管并发症中的可能作用。
J Proteomics. 2018 Sep 15;187:69-79. doi: 10.1016/j.jprot.2018.06.009. Epub 2018 Jun 21.
8
Mitochondrial dysfunction, oxidative stress and diabetic cardiovascular disorders.线粒体功能障碍、氧化应激与糖尿病心血管疾病
Cardiovasc Hematol Disord Drug Targets. 2012 Dec;12(2):106-12. doi: 10.2174/1871529x11202020106.
9
Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster.实验性糖尿病中心脏的病理生物学:糖尿病和/或高脂血症仓鼠中脂蛋白、免疫球蛋白G及晚期糖基化终末产物蛋白的免疫定位
Lab Invest. 1997 Jul;77(1):3-18.
10
Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells.糖化低密度脂蛋白通过抑制内皮细胞中剪切应力激活的L-精氨酸摄取来减弱剪切应力诱导的一氧化氮合成。
Diabetes. 1999 Jun;48(6):1331-7. doi: 10.2337/diabetes.48.6.1331.

引用本文的文献

1
Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers.21-羟化酶缺乏所致先天性肾上腺皮质增生症中的内皮功能障碍:当前认知与新型生物标志物
Front Endocrinol (Lausanne). 2025 Jun 3;16:1581681. doi: 10.3389/fendo.2025.1581681. eCollection 2025.
2
Associations of Multimarkers of Metabolic Malnutrition and Inflammation with All-Cause Mortality by Multimorbidity Status.代谢性营养不良和炎症的多种标志物与按多病共存状态划分的全因死亡率的关联。
Nutrients. 2025 May 22;17(11):1747. doi: 10.3390/nu17111747.
3
Immune cell contribution to vascular complications in diabetes.

本文引用的文献

1
CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy.CRISPR-Cas系统:人类疾病研究与基因治疗中的概述、创新及应用
Comput Struct Biotechnol J. 2020 Sep 8;18:2401-2415. doi: 10.1016/j.csbj.2020.08.031. eCollection 2020.
2
AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy.AGE/RAGE 信号转导介导的内质网应激与非编码 RNA 治疗糖尿病肾病的前景。
Biomed Pharmacother. 2020 Nov;131:110655. doi: 10.1016/j.biopha.2020.110655. Epub 2020 Aug 24.
3
Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets.
免疫细胞在糖尿病血管并发症中的作用。
Front Endocrinol (Lausanne). 2025 May 21;16:1549945. doi: 10.3389/fendo.2025.1549945. eCollection 2025.
4
Phytyl Phenolipids: Structurally Modified Antioxidants with Superior Lipid Membrane Interaction.植基酚脂质:具有卓越脂质膜相互作用的结构修饰抗氧化剂。
Molecules. 2025 May 17;30(10):2193. doi: 10.3390/molecules30102193.
5
Silicified curcumin microspheres Combats cardiovascular diseases via Nrf2/HO-1 pathway.硅化姜黄素微球通过Nrf2/HO-1途径对抗心血管疾病。
Bioact Mater. 2025 Mar 15;49:378-398. doi: 10.1016/j.bioactmat.2025.03.007. eCollection 2025 Jul.
6
High Glucose Treatment Induces Nuclei Aggregation of Microvascular Endothelial Cells via the - Pathway.高糖处理通过 - 途径诱导微血管内皮细胞核聚集。
Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):398-411. doi: 10.1161/ATVBAHA.124.321719. Epub 2025 Jan 30.
7
Endothelial KLF11 is a novel protector against diabetic atherosclerosis.内皮细胞 KLF11 是一种新型的糖尿病动脉粥样硬化保护因子。
Cardiovasc Diabetol. 2024 Oct 26;23(1):381. doi: 10.1186/s12933-024-02473-y.
8
Cholesteryl Phenolipids as Potential Biomembrane Antioxidants.胆甾醇基苯氧酸酯类作为潜在的生物膜抗氧化剂。
Molecules. 2024 Oct 20;29(20):4959. doi: 10.3390/molecules29204959.
9
The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study.血脂异常状态和甘油三酯-葡萄糖指数对糖尿病个体左心室整体功能和心肌微循环的差异影响:一项心脏磁共振研究。
Cardiovasc Diabetol. 2024 Sep 19;23(1):345. doi: 10.1186/s12933-024-02435-4.
10
The Blood Plasma Lipidomic Profile in Atherosclerosis of the Brachiocephalic Arteries.头臂动脉粥样硬化中的血浆脂质组学特征
Biomedicines. 2024 Jun 9;12(6):1279. doi: 10.3390/biomedicines12061279.
氧化应激与内皮功能障碍的新发病机制:潜在的诊断生物标志物和治疗靶点
J Clin Med. 2020 Jun 25;9(6):1995. doi: 10.3390/jcm9061995.
4
Alpha-Lipoic Acid as a Means of Influence on Systemic Inflammation in Type 2 Diabetes Mellitus Patients with Prior Myocardial Infarction.α-硫辛酸对既往有心肌梗死的2型糖尿病患者全身炎症的影响
J Med Life. 2020 Jan-Mar;13(1):32-36. doi: 10.25122/jml-2020-0018.
5
What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?脂蛋白(a)在被发现后的 57 年里,我们对其在动脉粥样硬化形成中的作用了解多少?
Prog Cardiovasc Dis. 2020 May-Jun;63(3):219-227. doi: 10.1016/j.pcad.2020.04.004. Epub 2020 Apr 8.
6
The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.α-硫辛酸补充对 2 型糖尿病患者 LP-PLA2 质量及其在 HDL 和载 apoB 脂蛋白间分布的有益影响:一项随机、双盲、安慰剂对照试验。
Oxid Med Cell Longev. 2020 Mar 9;2020:5850865. doi: 10.1155/2020/5850865. eCollection 2020.
7
Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models.晚期糖基化终末产物受体(RAGE)以及糖尿病和心血管疾病中的机制与治疗机遇:来自人类受试者和动物模型的见解
Front Cardiovasc Med. 2020 Mar 10;7:37. doi: 10.3389/fcvm.2020.00037. eCollection 2020.
8
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病:病理生理学、遗传学及治疗学见解:欧洲动脉粥样硬化学会共识小组的共识声明
Eur Heart J. 2020 Jun 21;41(24):2313-2330. doi: 10.1093/eurheartj/ehz962.
9
Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases.饮食相关疾病中的氧化还原信号与晚期糖基化终产物(AGEs)
Antioxidants (Basel). 2020 Feb 6;9(2):142. doi: 10.3390/antiox9020142.
10
Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells.可能的模式识别受体对巨噬样 RAW264.7 细胞中晚期糖基化终产物诱导的细胞反应的差异贡献。
Biotechnol Appl Biochem. 2020 Mar;67(2):265-272. doi: 10.1002/bab.1843. Epub 2019 Nov 6.